A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET

Clinical trial NCT05482971 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05482971
Sponsor: PharmaEssentia
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Essential Thrombocythemia

Start date: 2022-09-29
Primary completion: 2025-05-09
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.